{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:01:34Z","timestamp":1790596894002,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012569","name":"University of Toledo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cmi.2026.08.043","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:48:18Z","timestamp":1788796098000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunotherapy for invasive Candida infections: translating host-directed strategies into clinical practice"],"prefix":"10.1016","author":[{"given":"Rosanne","family":"Sprute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather R.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A.","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostinho","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.08.043_bib1","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/myc.13376","article-title":"Increasing morbidity and mortality of candidemia over one decade in a Swiss University Hospital","volume":"64","author":"Battistolo","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.cmi.2026.08.043_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/cid\/ciac004","article-title":"Attributable mortality of candida bloodstream infections in the modern era: A propensity score analysis","volume":"75","author":"Mazi","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib3","first-page":"25e280","article-title":"Global guideline for the diagnosis and management of candidiasis: An initiative of the ECMM in cooperation with ISHAM and ASM","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","article-title":"Immune responses to human fungal pathogens and therapeutic prospects","volume":"23","author":"Lionakis","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cmi.2026.08.043_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13054-016-1182-z","article-title":"T cells from patients with Candida sepsis display a suppressive immunophenotype","volume":"20","author":"Spec","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2026.08.043_bib6","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2025.24175","article-title":"Precision immunotherapy to improve sepsis outcomes: The ImmunoSep randomized clinical trial","volume":"335","author":"Giamarellos-Bourboulis","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2026.08.043_bib7","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1093\/cid\/ciag036","article-title":"Immunomodulation in the treatment of disseminated coccidioidomycosis","volume":"83","author":"Stephens","year":"2026","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-2334-14-166","article-title":"Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: A case series","volume":"14","author":"Delsing","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mib.2017.10.018","article-title":"Modulating host immune responses to fight invasive fungal infections","volume":"40","author":"Scriven","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.cmi.2026.08.043_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cncr.21142","article-title":"Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia","volume":"104","author":"Dignani","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2026.08.043_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/cid\/ciu215","article-title":"CARD9 deficiency and spontaneous central nervous system candidiasis: Complete clinical remission with GM-CSF therapy","volume":"59","author":"Gavino","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac535","article-title":"Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as adjuvant therapy for invasive fungal diseases","volume":"9","author":"Chen","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib13","series-title":"38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA","first-page":"479","article-title":"A double-blind, randomized, placebo-controlled phase II study of filgrastim (recombinant granulocyte colony-stimulating factor) in combination with fluconazole for treatment of invasive candidiasis and candidemia in nonneutropenic patients","author":"Kullberg","year":"1998"},{"key":"10.1016\/j.cmi.2026.08.043_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00817-21","article-title":"Candida auris bloodstream infection induces upregulation of the PD-1\/PD-L1 immune checkpoint pathway in an immunocompetent mouse model","volume":"7","author":"Wurster","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.cmi.2026.08.043_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3324\/haematol.2015.136630","article-title":"Impaired killing of Candida albicans by granulocytes mobilized for transfusion purposes: A role for granule components","volume":"101","author":"Gazendam","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.cmi.2026.08.043_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcyt.2012.11.014","article-title":"Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes","volume":"15","author":"Tramsen","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.cmi.2026.08.043_bib17","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2026.08.043_bib18","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1016\/j.ymthe.2025.09.003","article-title":"Adoptive transfer of NK cells engineered with a CD5-based chimeric antigen receptor (SRCD5CAR) to treat invasive fungal infections","volume":"33","author":"Velasco-de-Andr\u00e9s","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.cmi.2026.08.043_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1469-0691.2011.03676.x","article-title":"Adjunctive immunotherapy with recombinant cytokines for the treatment of disseminated candidiasis","volume":"18","author":"van de Veerdonk","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 4","key":"10.1016\/j.cmi.2026.08.043_bib20","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1086\/421960","article-title":"Design of efficacy trials of cytokines in combination with antifungal drugs","volume":"39","author":"Kullberg","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib21","article-title":"Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed mice","volume":"16","author":"Mattos","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2026.08.043_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2026.116244","article-title":"Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer","volume":"235","author":"Sandherr","year":"2026","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cmi.2026.08.043_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jinf.2021.12.009","article-title":"T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option","volume":"84","author":"Mellinghoff","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.cmi.2026.08.043_bib24","doi-asserted-by":"crossref","DOI":"10.1186\/cc12711","article-title":"Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis","volume":"17","author":"Chang","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2026.08.043_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","article-title":"Nivolumab plus interferon-\u03b3 in the treatment of intractable mucormycosis","volume":"17","author":"Grimaldi","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib26","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000530","article-title":"Immune checkpoint blockade for Aspergillosis and mucormycosis coinfection","volume":"5","author":"Banck","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.cmi.2026.08.043_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00230-26","article-title":"Emerging evidence for anti-PD-1 and IFN-\u03b3 as adjunctive immunotherapy in invasive mold infections","volume":"17","author":"Serris","year":"2026","journal-title":"MBio"},{"key":"10.1016\/j.cmi.2026.08.043_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mib.2020.09.007","article-title":"Immunotherapeutic approaches for fungal infections","volume":"58","author":"Williams","year":"2020","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.cmi.2026.08.043_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.seminhematol.2019.11.002","article-title":"Granulocyte transfusions: current science and perspectives","volume":"56","author":"West","year":"2019","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cmi.2026.08.043_bib30","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/trf.17950","article-title":"Optimized high-dose granulocyte transfusions for the treatment of infections in neutropenic patients: A single-center retrospective analysis","volume":"64","author":"Hadjiyannis","year":"2024","journal-title":"Transfusion"},{"key":"10.1016\/j.cmi.2026.08.043_bib31","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/JLB.4HI1221-722R","article-title":"Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections","volume":"111","author":"Sykes","year":"2022","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cmi.2026.08.043_bib32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1189\/jlb.0205072","article-title":"A phagocytic cell line markedly improves survival of infected neutropenic mice","volume":"78","author":"Spellberg","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cmi.2026.08.043_bib33","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1086\/652496","article-title":"Safety and efficacy of activated transfected killer cells for neutropenic fungal infections","volume":"201","author":"Lin","year":"2010","journal-title":"J Infect Dis"},{"issue":"Supplement_1","key":"10.1016\/j.cmi.2026.08.043_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4049\/jimmunol.184.Supp.38.18","article-title":"ATAK cells require intact cytochrome oxidase activity to kill fungi","volume":"184","author":"Lin","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.cmi.2026.08.043_bib35","first-page":"1734","article-title":"Posaconazole-loaded leukocytes as a novel treatment strategy targeting invasive pulmonary Aspergillosis","volume":"215","author":"Baistrocchi","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh1209","article-title":"CAR-T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models","volume":"14","author":"Seif","year":"2022","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cmi.2026.08.043_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659752","article-title":"CcpA- and Shm2-pulsed myeloid dendritic cells induce T-cell activation and enhance the neutrophilic oxidative burst response to Aspergillus fumigatus","volume":"12","author":"Page","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2026.08.043_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.mucimm.2024.01.003","article-title":"Immunity to pathogenic mucosal C. albicans infections mediated by oral megakaryocytes activated by IL-17 and candidalysin","volume":"17","author":"Launder","year":"2024","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.cmi.2026.08.043_bib39","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis; a phase 2 randomized, double-blind, placebo-controlled trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007460","article-title":"The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection","volume":"15","author":"Singh","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2026.08.043_bib41","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1038\/s41598-025-32488-8","article-title":"Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections","volume":"16","author":"Singh","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2026.08.043_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-025-01171-4","article-title":"Protective efficacy of the pan-fungal vaccine NXT-2 against vulvovaginal candidiasis in a murine model","volume":"10","author":"Wychrij","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.cmi.2026.08.043_bib43","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/vaccines13101033","article-title":"Active and passive immunization of pan-fungal vaccine NXT-2 reduces morbidity and mortality in an immunosuppressed murine model of Candida auris systemic infection","volume":"13","author":"Oworae","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.cmi.2026.08.043_bib44","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"De Bernardis","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.08.043_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41541-025-01183-0","article-title":"Pre-clinical evaluation of a divalent liposomal vaccine to control invasive candidiasis","volume":"10","author":"Costa-Barbosa","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.cmi.2026.08.043_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1021\/acsinfecdis.5b00104","article-title":"6-O-branched oligo-\u03b2-glucan-based antifungal glycoconjugate vaccines","volume":"2","author":"Liao","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2019.04.001","article-title":"Synthesis and immunological studies of \u03b2-1,2-mannan-peptide conjugates as antifungal vaccines","volume":"173","author":"Liao","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.cmi.2026.08.043_bib48","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1038\/s41467-018-07738-1","article-title":"Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis","volume":"9","author":"Rudkin","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2026.08.043_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01957-21","article-title":"Monoclonal antibodies targeting surface-exposed epitopes of Candida albicans cell wall proteins confer in vivo protection in an infection model","volume":"66","author":"Palliyil","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2026.08.043_bib50","article-title":"The prophylactic effects of monoclonal antibodies targeting the cell wall Pmt4 protein epitopes of Candida albicans in a murine model of invasive candidiasis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.cmi.2026.08.043_bib51","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.3390\/ijms22116162","article-title":"Candida cell-surface-specific monoclonal antibodies protect mice against Candida auris invasive infection","volume":"22","author":"Rosario-Colon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cmi.2026.08.043_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2025.2569629","article-title":"Mucosal passive immunization with monoclonal antibodies targeting Candidalysin and Hyr proteins attenuates vaginal candidiasis in mice","volume":"16","author":"Auffray","year":"2025","journal-title":"Virulence"},{"key":"10.1016\/j.cmi.2026.08.043_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2026.08.043_bib54","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.08.043_bib55","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2567.2004.01819.x","article-title":"Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2","volume":"111","author":"Vilanova","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.cmi.2026.08.043_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00312-20","article-title":"Vaccination with secreted aspartyl proteinase 2 protein from Candida parapsilosis can enhance survival of mice during C. tropicalis-mediated systemic candidiasis","volume":"88","author":"Shukla","year":"2020","journal-title":"Infect Immun"},{"issue":"suppl_1","key":"10.1016\/j.cmi.2026.08.043_bib57","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/mmy\/myx139","article-title":"Candida vaginitis: virulence, host response and vaccine prospects","volume":"56","author":"De Bernardis","year":"2018","journal-title":"Med Mycol"},{"key":"10.1016\/j.cmi.2026.08.043_bib59","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac248","article-title":"Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis","volume":"1","author":"Rayens","year":"2022","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.cmi.2026.08.043_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505340122","article-title":"Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development","volume":"122","author":"Reuber","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2026.08.043_bib61","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1016\/j.vaccine.2012.08.010","article-title":"A \u03b2-mannan trisaccharide conjugate vaccine aids clearance of Candida albicans in immunocompromised rabbits","volume":"30","author":"Lipinski","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2026.08.043_bib62","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3389\/fimmu.2014.00506","article-title":"Antifungal Th immunity: growing up in family","volume":"5","author":"Borghi","year":"2014","journal-title":"Front Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.cmi.2026.08.043_bib63","first-page":"ofac492","article-title":"97. A cross-kingdom vaccine protects against multiple healthcare-associated infections","volume":"9","author":"Singh","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2026.08.043_bib64","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/jof9010103","article-title":"Protective efficacy of anti-Hyr1p monoclonal antibody against systemic candidiasis due to multi-drug-resistant Candida auris","volume":"9","author":"Singh","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.cmi.2026.08.043_bib65","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2958.2004.04401.x","article-title":"PMT family of Candida albicans: Five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance","volume":"55","author":"Prill","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.cmi.2026.08.043_bib66","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1039\/D3SC01242E","article-title":"Synthesis of oligosaccharides to identify an immunologically active epitope against Candida auris infection","volume":"14","author":"Singh","year":"2023","journal-title":"Chem Sci"},{"key":"10.1016\/j.cmi.2026.08.043_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112459","article-title":"Monoclonal antibodies targeting Candida disrupt biofilms and inhibit growth across global clinical isolates","volume":"28","author":"Rosario-Colon","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.cmi.2026.08.043_bib68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cmi.2018.04.024","article-title":"Monoclonal antibodies as anti-infective products: A promising future?","volume":"25","author":"Pelfrene","year":"2019","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26004933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:35:14Z","timestamp":1790595314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26004933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"alternative-id":["S1198743X26004933"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.043","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy for invasive Candida infections: translating host-directed strategies into clinical practice","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}